SE416298B - Forfarande for framstellning av nya bensimidazolinon derivat - Google Patents
Forfarande for framstellning av nya bensimidazolinon derivatInfo
- Publication number
- SE416298B SE416298B SE7507026A SE7507026A SE416298B SE 416298 B SE416298 B SE 416298B SE 7507026 A SE7507026 A SE 7507026A SE 7507026 A SE7507026 A SE 7507026A SE 416298 B SE416298 B SE 416298B
- Authority
- SE
- Sweden
- Prior art keywords
- derivatives
- bensimidazolinon
- procedure
- preparation
- new
- Prior art date
Links
- SILNNFMWIMZVEQ-UHFFFAOYSA-N 1,3-dihydrobenzimidazol-2-one Chemical class C1=CC=C2NC(O)=NC2=C1 SILNNFMWIMZVEQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
- G01N21/766—Chemiluminescence; Bioluminescence of gases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/10—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using catalysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/173845—Amine and quaternary ammonium
- Y10T436/175383—Ammonia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/177692—Oxides of nitrogen
- Y10T436/178459—Only nitrogen dioxide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/481,594 US3989707A (en) | 1974-06-21 | 1974-06-21 | Benzimidazolinone derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7507026L SE7507026L (sv) | 1975-12-22 |
| SE416298B true SE416298B (sv) | 1980-12-15 |
Family
ID=23912586
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7507026A SE416298B (sv) | 1974-06-21 | 1975-06-18 | Forfarande for framstellning av nya bensimidazolinon derivat |
| SE7601636A SE415298B (sv) | 1974-06-21 | 1976-02-13 | Forfarande for bestemning av ammoniak i en gasblandning som innerhaller andelar av kveveoxid och kvevedioxid |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7601636A SE415298B (sv) | 1974-06-21 | 1976-02-13 | Forfarande for bestemning av ammoniak i en gasblandning som innerhaller andelar av kveveoxid och kvevedioxid |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US3989707A (de) |
| JP (1) | JPS5840553B2 (de) |
| AT (1) | AT345833B (de) |
| AU (1) | AU500910B2 (de) |
| BE (1) | BE830403A (de) |
| CA (1) | CA1053235A (de) |
| CH (1) | CH615173A5 (de) |
| CS (1) | CS190480B2 (de) |
| DE (1) | DE2527261C2 (de) |
| DK (1) | DK141751B (de) |
| ES (1) | ES438714A1 (de) |
| FI (1) | FI59589C (de) |
| FR (1) | FR2275210A1 (de) |
| GB (1) | GB1505173A (de) |
| HU (1) | HU170435B (de) |
| IE (1) | IE41383B1 (de) |
| IL (1) | IL47529A (de) |
| NL (1) | NL180587C (de) |
| NO (1) | NO142400C (de) |
| PH (1) | PH13604A (de) |
| PL (1) | PL98220B1 (de) |
| SE (2) | SE416298B (de) |
| SU (1) | SU585811A3 (de) |
| YU (1) | YU159475A (de) |
| ZA (1) | ZA753968B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4066772A (en) * | 1975-07-21 | 1978-01-03 | Janssen Pharmaceutica N.V. | 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds |
| NZ181256A (en) * | 1975-07-21 | 1978-04-28 | Janssen Pharmaceutica Nv | 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives |
| US4076821A (en) * | 1976-02-27 | 1978-02-28 | Yoshitomi Pharmaceutical Industries, Ltd. | 4,4-Diphenylcycloalkylpiperidines and psychotropic compositions thereof |
| US4219559A (en) * | 1979-01-10 | 1980-08-26 | Janssen Pharmaceutica N.V. | N-Heterocyclyl-4-piperidinamines |
| MA19091A1 (fr) * | 1980-03-10 | 1981-10-01 | Janssen Pharmaceutica Nv | Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine . |
| US4777265A (en) * | 1986-03-11 | 1988-10-11 | Basf Aktiengesellschaft | Preparation of acrylates and methacrylates |
| DE4107857A1 (de) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| WO1997040035A1 (en) | 1996-04-19 | 1997-10-30 | Neurosearch A/S | 1-(4-piperidyl)-benzimidazoles having neurotrophic activity |
| WO1998054168A1 (fr) * | 1997-05-30 | 1998-12-03 | Banyu Pharmaceutical Co., Ltd. | Derives de 2-0xoimidazole |
| WO2000031061A1 (fr) * | 1998-11-20 | 2000-06-02 | Banyu Pharmaceutical Co., Ltd. | Derives de 2-oxo-imidazole |
| MXPA02000340A (es) | 1999-07-21 | 2002-06-21 | Fujisawa Pharmaceutical Co | Derivados de benzimidazolona y su uso como inhibidores fosfodiesterasa. |
| US7244744B2 (en) * | 2001-11-01 | 2007-07-17 | Icagen, Inc. | Piperidines |
| US8288412B2 (en) * | 2005-09-30 | 2012-10-16 | Glaxo Group Limited | Compounds which have activity at M1 receptor and their uses in medicine |
| DE602006019119D1 (de) * | 2005-09-30 | 2011-02-03 | Glaxo Group Ltd | Verbindungen mit aktivität am m1-rezeptor und ihre verwendung in der medizin |
| JP5209479B2 (ja) * | 2005-09-30 | 2013-06-12 | グラクソ グループ リミテッド | Ｍ１受容体にて活性を有するベンゾイミダゾロン類 |
| GB0605784D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
| EP1997381A1 (de) * | 2007-06-01 | 2008-12-03 | Commissariat à l'Energie Atomique | Verwendung einer Verbindung mit Monogalactosyldiacylglycerol-Synthase-Hemmungsaktivität als Herbizid oder Algizid, Herbizid- und Algizidzusammensetzungen |
| GB0718415D0 (en) * | 2007-09-20 | 2007-10-31 | Glaxo Group Ltd | Compounds |
| KR20120062752A (ko) * | 2009-08-12 | 2012-06-14 | 얀센 파마슈티카 엔.브이. | 카텝신 ｓ 억제제의 제조 방법 |
| WO2022260016A1 (ja) * | 2021-06-07 | 2022-12-15 | 学校法人近畿大学 | Ｔ型カルシウムチャネル阻害剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633495A (de) * | 1962-06-13 | |||
| US3161645A (en) * | 1962-12-18 | 1964-12-15 | Res Lab Dr C Janssen N V | 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds |
| BE659364A (de) * | 1964-02-05 | |||
| US3799932A (en) * | 1970-03-20 | 1974-03-26 | Sumitomo Chemical Co | Gamma-piperidinobutyrophenones |
| JPS5511671B2 (de) * | 1971-08-26 | 1980-03-26 |
-
1974
- 1974-06-21 US US05/481,594 patent/US3989707A/en not_active Expired - Lifetime
-
1975
- 1975-04-25 PH PH17101A patent/PH13604A/en unknown
- 1975-05-14 AU AU81138/75A patent/AU500910B2/en not_active Expired
- 1975-05-15 NO NO751735A patent/NO142400C/no unknown
- 1975-05-19 FI FI751462A patent/FI59589C/fi not_active IP Right Cessation
- 1975-05-21 CA CA227,398A patent/CA1053235A/en not_active Expired
- 1975-05-23 GB GB22512/75A patent/GB1505173A/en not_active Expired
- 1975-05-27 CS CS753693A patent/CS190480B2/cs unknown
- 1975-06-12 FR FR7518434A patent/FR2275210A1/fr active Granted
- 1975-06-18 SE SE7507026A patent/SE416298B/xx unknown
- 1975-06-19 PL PL1975181386A patent/PL98220B1/pl unknown
- 1975-06-19 BE BE157471A patent/BE830403A/xx not_active IP Right Cessation
- 1975-06-19 JP JP50073830A patent/JPS5840553B2/ja not_active Expired
- 1975-06-19 DE DE2527261A patent/DE2527261C2/de not_active Expired
- 1975-06-19 HU HUJA735A patent/HU170435B/hu unknown
- 1975-06-19 ES ES438714A patent/ES438714A1/es not_active Expired
- 1975-06-20 AT AT476175A patent/AT345833B/de not_active IP Right Cessation
- 1975-06-20 CH CH809875A patent/CH615173A5/de not_active IP Right Cessation
- 1975-06-20 NL NLAANVRAGE7507368,A patent/NL180587C/xx not_active IP Right Cessation
- 1975-06-20 ZA ZA3968A patent/ZA753968B/xx unknown
- 1975-06-20 IE IE1381/75A patent/IE41383B1/xx unknown
- 1975-06-20 IL IL47529A patent/IL47529A/xx unknown
- 1975-06-20 SU SU752148462A patent/SU585811A3/ru active
- 1975-06-20 DK DK281975AA patent/DK141751B/da not_active IP Right Cessation
- 1975-07-20 YU YU01594/75A patent/YU159475A/xx unknown
-
1976
- 1976-02-13 SE SE7601636A patent/SE415298B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE416298B (sv) | Forfarande for framstellning av nya bensimidazolinon derivat | |
| SE7604052L (sv) | Nya erytromycinderivat och forfarande for framstellning derav | |
| SE403371B (sv) | Forfarande for framstellning av vissa angivna (1-hydroximino-2,2-disubstituerad-5-indanyloxi)-lagalkylansyror | |
| SE7608808L (sv) | Forfarande for framstellning av nya derivat av tiazolo/3,4-b/isokinolin | |
| SE416811B (sv) | Analogiforfarande for framstellning av nya, antibakteriellt aktiva derivat av amidinopenicillansyra | |
| SE7504842L (sv) | Forfarande for framstellning av adeninderivat.. | |
| DK139580B (da) | Analogifremgangsmåde til fremstilling af additionssalte af piperidylindolderivater. | |
| SE405598B (sv) | Forfarande for framstellning av nya terapeutiskt verksamma derivat av 4-(3-amino-2-hydroxi-propoxi)-indol | |
| SE402009B (sv) | Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat | |
| SE7513640L (sv) | Forfarande for framstellning av 6-metyl-8-(substituerade) metylerogoliner | |
| SE7509764L (sv) | Forfarande for framstellning av omega-nor-cykloalkyl-13,14-dehydro-prostaglandiner | |
| SE7508793L (sv) | Antibiotiska derivat av xk-62-2 samt forfarande for framstellning derav | |
| SE7507648L (sv) | Forfarande for framstellning av basiskt substituerade derivat av 4-hydroxi-bensimidazol | |
| NO142524C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater | |
| SE424638B (sv) | Analogiforfarande for framstellning av 5,7-dihydroxi-tetrahydroisokinolin derivat | |
| SE404367B (sv) | Forfarande for framstellning av derivat av homofolsyra | |
| FI55037B (fi) | Foerfarande foer framstaellning av d-homosteroider med endokrin verkan | |
| DK138540B (da) | Analogifremgangsmåde til fremstilling af benzhydryloxyalkylaminderivater eller farmaceutisk acceptable syreadditionssalte deraf. | |
| SE7610968L (sv) | Forfarande for framstellning av biologiskt aktiva di-karboxylsyraderivat | |
| SE7504507L (sv) | Forfarande for framstellning av 5-nitroimidazolderivat. | |
| SE7600687L (sv) | Forfarande for framstellning av n-tricykliska derivat av azetidin | |
| DK136189B (da) | Analogifremgangsmåde til fremstilling af benzo(c)(1,6)naphthyridinderivater eller syreadditionssalte deraf. | |
| SE7505066L (sv) | Forfarande for framstellning av cefalsporinderivat. | |
| SE7607753L (sv) | Forfarnde for framstellning av derivat av alfafenylpropionsyra | |
| SE416726B (sv) | Forfarande for framstellning av nya dibensylglykolsyra derivat |